The R&D center covers an area of 2,400 square meters, equipment with a total assets of more than CNY 30 million. R&D center has more than 30 experts, including five technical and consultant experts, three postdoctoral researchers, six doctors, one Huanghe Delta distinguished expert, and one urgently-needed talent in Huanghe Delta. At present the center mainly focus on the development of blood products and polysaccharide related products. As the second phase project is completed in the future, the R&D center will rapidly expand its product development area.
The group company respectively in Shanghai and Dongying has two R & D center, built provincial enterprise technology centers, post doctoral scientific research workstation and Shandong Province biochemical pharmaceutical engineering laboratory research and development platform, and national glycoengineering Research Center, Shandong University keep good close relations.
R&D Center has established cooperation with domestic and foreign research institutions, CROs, consultation companies, big data platforms, etc. Rapid market response mechanism is set up to develop new products integrating various resources based on project needs, as well as to offer efficient technical services to clients.development needs, the rapid integration of resources, to promote the development of new products with flexible and diverse ways, but also to provide customers with fast technical services.
Copyright © 2015 Tian Dong pharmaceutical. All Rights Reserved